blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1370539

EP1370539 - HIV INHIBITING N-AMINOIMIDAZOLE DERIVATIVES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  14.09.2012
Database last updated on 15.08.2024
Most recent event   Tooltip26.10.2012Lapse of the patent in a contracting statepublished on 28.11.2012  [2012/48]
Applicant(s)For all designated states
K.U. Leuven Research and Development
Groot Begijnhof, Benedenstraat 59
3000 Leuven / BE
[N/P]
Former [2003/51]For all designated states
K.U. Leuven Research and Development
Groot Begijnhof, Benedenstraat 59
3000 Leuven / BE
Inventor(s)01 / DE CLERCQ, Erik
Parklaan 9
B-3360 Lovenjoel / BE
02 / VAN AERSCHOT, Arthur
Heist-Goostraat 29
B-2220 Heist-op-den-Berg / BE
03 / HERDEWIJN, Piet
Olivierstraat 21
B-3111 Wezemaal / BE
04 / LAGOJA, Irene
P. Poulletlaan 5/113
B-3000 Leuven / BE
05 / PANNECOUCQUE, Christophe
Tervuursevest 166/2
B-3000 Leuven / BE
 [2003/51]
Representative(s)Bird, Ariane, et al
Bird Goën & Co
Wetenschapspark Arenberg
Gaston Geenslaan 9
3001 Heverlee / BE
[N/P]
Former [2003/51]Bird, Ariane, et al
Bird Goen & Co, Klein Dalenstraat 42A
3020 Winksele / BE
Application number, filing date01919343.223.02.2001
[2003/51]
WO2001EP02140
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO02068395
Date:06.09.2002
Language:EN
[2002/36]
Type: A1 Application with search report 
No.:EP1370539
Date:17.12.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 06.09.2002 takes the place of the publication of the European patent application.
[2003/51]
Type: B1 Patent specification 
No.:EP1370539
Date:09.11.2011
Language:EN
[2011/45]
Search report(s)International search report - published on:EP06.09.2002
ClassificationIPC:C07D233/84, A61K31/415, C07D233/90, C07D233/54, A61P31/12, A61P31/18
[2003/51]
CPC:
C07D233/54 (EP,US); C07D233/84 (KR); A61P31/12 (EP);
A61P31/18 (EP); A61P35/00 (EP)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/51]
TitleGerman:HIV HEMMENDE N-AMINOIMIDAZOLDERIVATE[2003/51]
English:HIV INHIBITING N-AMINOIMIDAZOLE DERIVATIVES[2003/51]
French:DERIVES N-AMINOIMIDAZOLE INHIBANT LE VIH[2003/51]
Entry into regional phase12.08.2003National basic fee paid 
12.08.2003Designation fee(s) paid 
12.08.2003Examination fee paid 
Examination procedure22.08.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
12.08.2003Examination requested  [2003/51]
21.10.2003Amendment by applicant (claims and/or description)
23.06.2004Despatch of a communication from the examining division (Time limit: M06)
08.11.2004Reply to a communication from the examining division
07.05.2009Despatch of a communication from the examining division (Time limit: M06)
17.11.2009Reply to a communication from the examining division
22.07.2010Despatch of a communication from the examining division (Time limit: M02)
01.10.2010Reply to a communication from the examining division
13.01.2011Despatch of a communication from the examining division (Time limit: M01)
16.02.2011Reply to a communication from the examining division
26.04.2011Communication of intention to grant the patent
02.09.2011Fee for grant paid
02.09.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  23.06.2004
Opposition(s)10.08.2012No opposition filed within time limit [2012/42]
Fees paidRenewal fee
12.08.2003Renewal fee patent year 03
06.04.2004Renewal fee patent year 04
07.12.2004Renewal fee patent year 05
05.01.2006Renewal fee patent year 06
16.01.2007Renewal fee patent year 07
11.02.2008Renewal fee patent year 08
23.02.2009Renewal fee patent year 09
22.02.2010Renewal fee patent year 10
07.02.2011Renewal fee patent year 11
Penalty fee
Additional fee for renewal fee
29.02.200404   M06   Fee paid on   06.04.2004
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipSE24.02.2012
[2012/48]
Cited inInternational search[A]EP0700911  (SHIONOGI & CO [JP]) [A] 1-37 * claim 1 *;
 [A]EP0786455  (SHIONOGI & CO [JP]) [A] 1-37 * claim 1 *;
 [A]  - LAGOJA, IRENE M. ET AL, "Glycosylation of 1-aminoimidazole-2(3H)-thiones", COLLECT. CZECH. CHEM. COMMUN. (2000), 65(7), 1145-1155, XP001028908 [A] 1 * page 1146; examples 1A-1C *

DOI:   http://dx.doi.org/10.1135/cccc20001145
 [A]  - SCHANTL, JOACHIM G. ET AL, "1-Arylamino-1H-imidazoles by "oxidative reduction" - conversion of 1-arylamino-2,3-dihydro-1H-imidazole-2-thiones", HETEROCYCLES (1998), 48(5), 929-938, XP001019139 [A] 1 * Scheme 1; page 930 *
 [A]  - SCHANTL, JOACHIM G. ET AL, "Direct synthetic approach to N-substituted 1-amino-2,3-dihydro-1H- imidazole-2-thiones", HETEROCYCLES (1997), 45(4), 691-700, XP001019137 [A] 1 * Compounds 8; page 692 *
 [DA]  - SALASKI E J, "Synthesis of Imidazobenzazepinthiones: A New Series of HIV-1 Reverse Transcriptase Inhibitors", TETRAHEDRON LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, (19950227), vol. 36, no. 9, ISSN 0040-4039, pages 1387 - 1390, XP004028581 [DA] 1-37 * the whole document *

DOI:   http://dx.doi.org/10.1016/0040-4039(95)00006-X
 [A]  - BUTLER, RICHARD N. ET AL, "1,2,3-Triazolium-1-oxide, -1-imide and 1-methanide hetero-1,3,5-triene equilibrium: ab initio calculations. A new base-induced ring expansion of 1-alkyl-1,2,3-triazolium salts to 2,3-dihydro-1,2,4-triazines and 1-aminoimidazoles via the 1,2,5-triazahexa-1,3,5-triene system. Azolium 1,3-dipoles", J. CHEM. SOC., PERKIN TRANS. 1 (1992), (1), 147-52, XP001028983 [A] 1 * table 1 *
by applicant   - I.M. LAGOJA; A. VAN AERSCHOT; C. HENDRIX; P. HERDEWIJN, COLLECT. CZECH. CHEM. COMMUN., (2000), vol. 65, pages 1145 - 1155
    - J.G. SCHANTL; I.M. LAGOJA, HETEROCYCLES, (1997), vol. 45, page 691
    - J.G. SCHANTL; I.M. LAGOJA, HETEROCYCLES, (1998), vol. 48, page 929
    - AIDS, SCIENCE, vol. 220, pages 868 - 871
    - MIYOSHI, I.; TAGUCHI, H.; KOBONISHI, I.; YOSHIMOTO, S.; OHTSUKI, Y.; SHIRAISHI, Y.; AKAGI,T., "Type C virus-producing cell lines derived from adult T cell leukemia", GANN MONGR, (1982), vol. 28, pages 219 - 228
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.